AU2003219059A1 - Use of polypeptides of human origin for the treatment of microbial infectious diseases - Google Patents

Use of polypeptides of human origin for the treatment of microbial infectious diseases

Info

Publication number
AU2003219059A1
AU2003219059A1 AU2003219059A AU2003219059A AU2003219059A1 AU 2003219059 A1 AU2003219059 A1 AU 2003219059A1 AU 2003219059 A AU2003219059 A AU 2003219059A AU 2003219059 A AU2003219059 A AU 2003219059A AU 2003219059 A1 AU2003219059 A1 AU 2003219059A1
Authority
AU
Australia
Prior art keywords
polypeptides
treatment
infectious diseases
human origin
microbial infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003219059A
Inventor
Petra Derr
Christiane Kirchhoff
Hans Henning Von Horsten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAGOW GmbH
Original Assignee
LAGOW GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAGOW GmbH filed Critical LAGOW GmbH
Publication of AU2003219059A1 publication Critical patent/AU2003219059A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003219059A 2002-03-15 2003-03-14 Use of polypeptides of human origin for the treatment of microbial infectious diseases Abandoned AU2003219059A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10211545A DE10211545A1 (en) 2002-03-15 2002-03-15 Use of polypeptides of human origin for the treatment of microbial infectious diseases
DE10211545.1 2002-03-15
PCT/EP2003/002705 WO2003077938A1 (en) 2002-03-15 2003-03-14 Use of polypeptides of human origin for the treatment of microbial infectious diseases

Publications (1)

Publication Number Publication Date
AU2003219059A1 true AU2003219059A1 (en) 2003-09-29

Family

ID=27797805

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003219059A Abandoned AU2003219059A1 (en) 2002-03-15 2003-03-14 Use of polypeptides of human origin for the treatment of microbial infectious diseases

Country Status (3)

Country Link
AU (1) AU2003219059A1 (en)
DE (1) DE10211545A1 (en)
WO (1) WO2003077938A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1486801A (en) * 1999-11-15 2001-05-30 Curagen Corporation Novel growth factor polypeptides and nucleic acids encoding same
US20040072777A1 (en) * 2000-01-05 2004-04-15 Otto Froelich Epididymal antimicrobial peptides

Also Published As

Publication number Publication date
DE10211545A1 (en) 2003-10-02
WO2003077938A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004041170A9 (en) Compositions and methods for the treatment of immune related diseases
AU2003256253A1 (en) Aerosol for medical treatment and methods
AU2003243150A1 (en) Resorption-controllable medical implants
AU2003253106A1 (en) Medical implant
AU2003239568A1 (en) Pyrrolotriazinone compounds and their use to treat diseases
AU2003285091A1 (en) Interferon antagonists useful for the treatment of interferon related diseases
AU2003232258A1 (en) Medical implant
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2003258298A1 (en) Medical implants
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003298911A1 (en) Cyclosporins for the treatment of autoimmune diseases
SI1487828T1 (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
AU2003267532A1 (en) PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES
AU2003289694A1 (en) Human body supporting device
AU2003303217A1 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2003246592A1 (en) Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2003222250A1 (en) Treatment of autoimmune diseases
AU2003256112A1 (en) Patient bed
GB0201025D0 (en) The treatment of degenerative diseases
AU2003219059A1 (en) Use of polypeptides of human origin for the treatment of microbial infectious diseases
AU2003236999A1 (en) Medical care experience

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase